Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Enrolling by invitation × Multiple Myeloma × Lenalidomide × Clear all

Phase

Status

Completed 160 Active not recruiting 73 Recruiting 44 Terminated 40 Withdrawn 17 Unknown 17 Not yet recruiting 6 No longer available 2 Suspended 1 Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 1 Lymphoma, Large B-Cell, Diffuse 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia, B-Cell 1

Interventions

Lenalidomide 1 Dexamethasone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07210047 2025-10-07

Study of HuL001 in Relapsed/Refractory Multiple Myeloma Patients

HuniLife Biotechnology, Inc.

Phase 1/2 Enrolling by invitation

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡